Janssen Inc (Janssen) brought two Applications pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations.
March 02, 2015
In a highly anticipated ruling, on 15 January 2015, the CJEU held in a preliminary reference made to it in Ryanair Limited v PR Aviation BV that databases which are
February 16, 2015
Janssen appealed from the decision of Justice Barnes of the Federal Court refusing to prohibit the Minister of Health from issuing a Notice of Compliance to Teva.
February 10, 2015
On January 23, 2015, the Federal Court released its public reasons for Judgment granting Eli Lilly and Company and Eli Lilly Canada patent infringement damages.
January 30, 2015
The Collège des médecins du Québec (the CMQ) has made various changes to the Code of ethics of physicians.
January 29, 2015
On November 28, 2014, the Quebec government introduced Bill 20
January 14, 2015
The Federal Court released two decisions on December 19, 2014 granting the innovators’ applications to set aside the Minister’s decision.
On December 23, 2014, Apotex Inc. and Mylan Pharmaceuticals ULC each filed Supreme Court of Canada (SCC) applications.
January 06, 2015
In April 2014, Health Canada launched its Regulatory Transparency and Openness Framework (“RTOF”).
Bill 21, Safeguarding Health Care Integrity Act, 2014, was proposed on July 22, 2014, and received Royal Assent on December 11, 2014.
Try searching our global site instead